Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients

Status No longer available

Clinical Trial Summary

Currently there are no approved therapies for lung transplant recipients in the United States (US). Treatment with CIS following lung transplantation has previously been demonstrated to result in a clinically meaningful improvement in survival and chronic rejection-free survival compared to placebo, but additional data supporting its use is needed prior to Food and Drug Administration (FDA) approval. This treatment use protocol is a mechanism for providing eligible lung transplant recipients early access to CIS in advance of FDA approval.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

Lung Transplant

Clinical Trial Details

NCT number	NCT00633373
Study type	Expanded Access
Source	APT Pharmaceuticals, Inc.
Contact
Status	No longer available
Phase	N/A

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05404919` - Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates	Phase 2
Completed	`NCT03299504` - Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation
Completed	`NCT00755781` - Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation	Phase 3
Recruiting	`NCT05547698` - A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation	N/A
Terminated	`NCT03207399` - Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment	Phase 4
Completed	`NCT03300882` - PREDICT Cytomegalovirus (CMV)
Recruiting	`NCT05101460` - An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
Completed	`NCT03150095` - Health Coaching to Improve Self-Management in Thoracic Transplant Candidates	N/A
Completed	`NCT04420195` - Envarsus XR in Lung Transplant	Phase 2
Recruiting	`NCT02235610` - Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation	N/A
Not yet recruiting	`NCT06066229` - Identification of Patient Important Outcomes in Lung Transplantation
Recruiting	`NCT04601818` - Planned Semi-Elective Lung Tx Study	N/A
Recruiting	`NCT03072589` - Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation	Phase 1
Completed	`NCT01963780` - International EXPAND Lung Pivotal Trial	N/A
Recruiting	`NCT05671887` - DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Completed	`NCT03987113` - Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
Recruiting	`NCT02748798` - Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders	Early Phase 1
Completed	`NCT03167528` - Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients	N/A
Active, not recruiting	`NCT04244734` - Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.	N/A
Active, not recruiting	`NCT01365429` - Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs	N/A